REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 27th, 2023 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 22, 2023, between Harpoon Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several investors signatory hereto (each, an “Investor” and, collectively, the “Investors”).
COMMON STOCK PURCHASE WARRANT HARPOON THERAPEUTICS, INC.Security Agreement • March 27th, 2023 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Warrant is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated March 22, 2023, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2023 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 22, 2023, between Harpoon Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers identified on the signature pages hereto (each, including its respective successors and assigns, a “Purchaser”).
